ARCHIVES

NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions

This article is from The Cancer Letter archive.

Vol. 06 No. 44 | November 7, 1980

Download PDF Visit The Full Archive

Related Articles

Has The Pendulum Swing too Far Toward Grants? NCI, NCAB Ponder Best Way to Stimulate Work In New areas

December 5, 1980

“Critical Issues” Include How U.S. NCI Spends Its Money. “Catastrophic” Cutback In Canada

May 14, 1976

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

No Protective Effect From Long-Term Vitamin E or C

November 28, 2008